SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-137643
Filing Date
2021-11-12
Accepted
2021-11-12 09:03:37
Documents
15
Period of Report
2021-11-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2132715d1_8k.htm   iXBRL 8-K 28839
2 EXHIBIT 99.1 tm2132715d1_ex99-1.htm EX-99.1 80116
7 GRAPHIC tm2132715d1_ex99-1img001.jpg GRAPHIC 3056
  Complete submission text file 0001104659-21-137643.txt   351015

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vacc-20211112.xsd EX-101.SCH 3707
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vacc-20211112_def.xml EX-101.DEF 27295
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE vacc-20211112_lab.xml EX-101.LAB 37338
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vacc-20211112_pre.xml EX-101.PRE 25920
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2132715d1_8k_htm.xml XML 5425
Mailing Address THE SCHRODINGER BUILDING HEATLEY ROAD, THE OXFORD SCIENCE PARK OXFORD X0 OX4 4GE
Business Address THE SCHRODINGER BUILDING HEATLEY ROAD, THE OXFORD SCIENCE PARK OXFORD X0 OX4 4GE 44 (0) 1865 818808
Vaccitech plc (Filer) CIK: 0001828185 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40367 | Film No.: 211400261
SIC: 2834 Pharmaceutical Preparations